Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Ferroptosis Compound Library: Tools for Cell Death Research

Ferroptosis Compound Library is a systematically curated collection of small-molecule inducers and inhibitors purpose-built to accelerate mechanistic and translational research into iron-dependent, lipid-peroxidation-driven cell death.

Selleck Reference Number
L6400
Application
Screening inducers and inhibitors of ferroptosis for mechanistic and drug-discovery studies
Research Area
Ferroptosis, oxidative cell death, cancer biology, neurodegeneration
Format
Pre-plated compound library of small molecules

What Is Ferroptosis and Why Does It Matter?

Ferroptosis is a form of regulated, non-apoptotic cell death driven by the iron-catalyzed accumulation of lethal lipid peroxides within cellular membranes. First formally defined in 2012, it is mechanistically distinct from apoptosis, necroptosis, and autophagy, and is characterized by depletion of glutathione (GSH), inactivation of glutathione peroxidase 4 (GPX4), and uncontrolled oxidation of polyunsaturated fatty acid (PUFA)-containing phospholipids.

The pathway has attracted intense scientific interest because dysregulation of ferroptosis is implicated in a wide range of diseases, including therapy-resistant cancers, ischemia–reperfusion injury, neurodegeneration (Alzheimer's and Parkinson's diseases), and acute organ injury. Conversely, deliberate induction of ferroptosis represents a promising therapeutic strategy against tumors that have acquired resistance to conventional apoptosis-inducing agents.

Key regulatory nodes include the cystine/glutamate antiporter system Xc⁻ (SLC7A11/SLC3A2), the GPX4 enzyme, the mevalonate pathway (which supplies CoQ10 and squalene as lipophilic antioxidants), and the ferroptosis suppressor protein FSP1. Understanding and modulating these nodes requires well-validated chemical probes—precisely the purpose served by a dedicated compound library.

Ferroptosis Compound Library: Composition and Key Features

The Ferroptosis Compound Library (Lib412068), referenced under Selleck number L6400, is a pre-plated collection of small molecules specifically selected for their documented roles in ferroptosis biology. The library encompasses compounds spanning multiple mechanistic categories:

  • GPX4 inhibitors – direct inactivators of the master lipid hydroperoxide reductase, used to trigger ferroptosis in cellular models.
  • System Xc⁻ inhibitors – agents that block cystine import, thereby depleting intracellular GSH and sensitizing cells to lipid peroxidation.
  • Lipid peroxidation modulators – compounds that either amplify or quench reactive oxygen species (ROS) at the membrane level.
  • Iron metabolism regulators – tools to manipulate labile iron pools and transferrin receptor activity.
  • Ferroptosis inhibitors and rescue compounds – including lipophilic antioxidants and radical-trapping agents, essential for mechanistic controls and therapeutic lead identification.

Each compound in the library is supplied with purity and quality data, enabling researchers to proceed directly to biological assays with confidence. The pre-plated, ready-to-screen format saves significant preparation time compared with sourcing and reformatting individual compounds.

Applications in Ferroptosis Research and Drug Discovery

The Ferroptosis Compound Library supports a broad spectrum of experimental workflows:

Mechanistic pathway dissection: By applying individual library compounds or defined sub-sets, researchers can map the contribution of specific nodes—GPX4, FSP1, ACSL4, LPCAT3—to ferroptotic sensitivity in their cell line or tissue of interest. Dose–response profiling of inducers alongside rescue experiments with matched inhibitors provides rigorous mechanistic evidence.

High-throughput and medium-throughput screening (HTS/MTS): The pre-plated format is compatible with standard 96- and 384-well plate readers equipped for fluorescence (C11-BODIPY lipid peroxidation sensor, TBARS assay) or luminescence (CellTiter-Glo viability). This allows rapid identification of novel ferroptosis modulators or sensitizers within larger compound collections.

Cancer biology and therapy resistance: Ferroptosis inducers have shown efficacy against mesenchymal, drug-tolerant persister, and RAS-mutant cancer cells that evade apoptosis. The library facilitates systematic evaluation of which compounds synergize with standard-of-care chemotherapy or immunotherapy regimens.

Neuroprotection and ischemia models: Ferroptosis inhibitors within the library serve as reference tools in neuronal culture models of oxidative stress, as well as in ex vivo organ slice assays relevant to stroke and kidney injury research.

Target identification and validation: Chemoproteomic approaches can be anchored to library compounds with known targets, helping to deconvolute off-target activity of novel probes.

Experimental Considerations and Best Practices

To obtain reproducible, biologically meaningful results with the Ferroptosis Compound Library, researchers should observe the following guidance:

Solvent and stability: Most library compounds are dissolved in DMSO. Final DMSO concentrations in cell culture media should be kept at or below 0.1% (v/v) to avoid confounding cytotoxicity. Aliquot stocks to minimize freeze–thaw cycles and store according to the data sheet conditions provided with each compound.

Cell model selection: Ferroptotic sensitivity varies markedly between cell lines due to differences in basal GSH levels, GPX4 expression, PUFA content, and iron handling. Pilot experiments to establish the ferroptotic window (EC₅₀ of inducer vs. rescue concentration of inhibitor) are strongly recommended before library-wide screening.

Readout selection: Cell viability assays (ATP-based luminescence) measure overall outcome but lack specificity. Pairing viability with a lipid peroxidation reporter (e.g., C11-BODIPY 581/591 by flow cytometry or imaging) and an iron chelator rescue control (e.g., deferoxamine) provides high-confidence ferroptosis attribution.

Positive and negative controls: Include a validated GPX4 inhibitor (positive ferroptosis inducer control) and a lipophilic antioxidant such as ferrostatin-1 or liproxstatin-1 (inhibitor rescue control) in every assay plate to monitor assay performance and calculate Z′ factors for HTS validation.

Data interpretation: Distinguish ferroptosis from other oxidative cell death modalities by confirming that the caspase inhibitor z-VAD-FMK does not rescue the phenotype, whereas lipid ROS scavengers do—a hallmark of genuine ferroptotic death.

Frequently asked questions

What types of compounds are included in the Ferroptosis Compound Library?

The Ferroptosis Compound Library (Lib412068) contains small molecules spanning multiple mechanistic categories relevant to ferroptosis, including GPX4 inhibitors, system Xc⁻ inhibitors, lipid peroxidation modulators, iron metabolism regulators, and ferroptosis rescue compounds such as lipophilic antioxidants and radical-trapping agents. This diversity allows researchers to probe multiple nodes of the ferroptosis pathway within a single library.

How should the Ferroptosis Compound Library be stored to maintain compound integrity?

Compounds in the library are typically supplied dissolved in DMSO and should be stored according to the individual data sheets provided with each compound. In general, minimizing freeze–thaw cycles through single-use aliquoting, protecting from light, and maintaining appropriate low-temperature storage conditions are essential practices. Consult the specific storage recommendations supplied with the Ferroptosis Compound Library (Lib412068) for authoritative guidance.

Is the Ferroptosis Compound Library suitable for high-throughput screening?

Yes. The pre-plated format of the Ferroptosis Compound Library (Lib412068) is compatible with standard 96- and 384-well plate-based detection platforms, including ATP-luminescence viability assays and fluorescence-based lipid peroxidation sensors. Researchers conducting HTS campaigns should include validated inducer and inhibitor controls on each plate and calculate Z′ factors to confirm assay robustness before large-scale screening.

How can I confirm that observed cell death is genuinely ferroptosis and not another death modality?

The gold-standard approach is to demonstrate that cell death is rescued by lipophilic antioxidants or radical-trapping agents (such as ferrostatin-1 or liproxstatin-1) and by iron chelators (such as deferoxamine), but not by the pan-caspase inhibitor z-VAD-FMK. Additionally, confirming elevated lipid ROS using a probe such as C11-BODIPY 581/591 by flow cytometry provides mechanistic specificity. Using both inducer and inhibitor compounds from the Ferroptosis Compound Library in paired experiments strengthens this attribution.

References

  1. Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
  2. Stockwell BR, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285. doi:10.1016/j.cell.2017.09.021
  3. Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nature Reviews Molecular Cell Biology. 2021;22(4):266–282. doi:10.1038/s41580-020-00324-8
  4. Bersuker K, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688–692. doi:10.1038/s41586-019-1705-2

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Ferroptosis Compound Library: Tools for Cell Death Research" Aladdin Knowledge Base, updated 2026/11/19. https://www.aladdinsci.com/us_ja/faqs/ferroptosis-compound-library-cell-death-research-en.html
Was this article helpful? Yes No 3 out of 7 found this helpful

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.